Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

During the Trading Day
379.01 +11.77 / +3.20%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
379.06 +0.0455 / +0.01%
Volume: 10.2K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 1
Quarter 2
Quarter 3
Quarter 4
Operating ActivitiesNet Income / Starting Line76.0M194.6M210.4M--
Total Other Cash Flow113.1M122.2M115.5M--
Funds From Operations194.2M284.0M339.7M--
Funds From/For Other Operating Expenses281.7M40.4M-553.2M--
Net Cash Flow - Operating Activities-87.5M243.6M892.9M--
InvestingIncrease In Investments-95.8M-245.1M-209.3M--
Decrease In Investments80.5M113.3M72.2M--
Capital Expenditures-114.2M-239.9M-146.1M--
Net Cash Flow Investing-129.5M-371.6M-283.2M--
FinancingShort Term Borrowings0.00--------
Long Term Borrowings0.0026.8M-375.0K--
Long Term Debt Reduction-9.9M-134.1M-2.0M--
Net Proceeds Stock Sale76.3M39.6M34.6M--
Common Preferred Redeemed0.000.000.00----
Common Dividends----------
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing155.6M93.1M56.8M--
Other Uses - Financing145.7M14.7M434.7M--
Net Cash Flow - Financing76.2M10.7M-345.6M--
Exchange RateEffect of Exchange Rate on Cash----0.00----
Net Change In Cash-140.8M-117.4M264.0M0.00